Tango Therapeutics (TNGX) Q4 Loss Narrows to $0.29/Share vs $0.33 Estimate; Shares Surge 23%
Tango Therapeutics posts narrower-than-expected Q4 loss of $0.29/share vs $0.33 estimate; shares jump 23% on the biotech's results.
Tango Therapeutics posts narrower-than-expected Q4 loss of $0.29/share vs $0.33 estimate; shares jump 23% on the biotech's results.
Alight, Inc. (NYSE: ALIT), a provider of benefits administration and cloud-based human capital solutions with a market capitalization of approximately...
SiriusPoint Ltd (NYSE: SPNT), a Bermuda-based specialty insurer and reinsurer, reported record full-year 2025 results, underscoring its strategic repositioning toward...
Air France‑KLM S.A. (Euronext: AF) Market Cap ~€3.1 billion — Europe’s integrated airline group combining Air France and KLM Royal Dutch...
Rivian shares drop 5.2% as investors lock in profits following last week's 27% post-earnings surge, with volume signaling technical consolidation.
ACN extends monthlong selloff, dropping 5.5% to $212.25 with no clear catalyst as shares trade 21% below 200-day average ahead…
BKNG plunges 7.65% to $3,925.75 despite beating Q4 EPS estimates by 0.27%, extending losses to 25.8% from January highs on…
AdvanSix crashes 80% below EPS estimates at $0.08 vs $0.40 consensus as chemical demand weakness deepens and margins turn negative.
EnWave Q1 fiscal 2026 data unavailable; prior guidance points to 6-8 machine deployments and undisclosed product launches ahead.
Sienna Senior Living acquires GTA and BC properties ahead of Q4 results, signaling M&A momentum as occupancy hits 95%.